Gentherm (THRM) Q1: $394M revenue, HSR cleared for Modine deal; S-4 planned
Rhea-AI Filing Summary
Gentherm presented Q1 results and discussed its planned combination with Modine Performance Technologies and SpinCo. Product revenue was $394 million, a record quarterly result, and the company secured $395 million of automotive new business awards. Management reported $49.3 million of adjusted EBITDA (12.5% of sales) and adjusted diluted EPS of $0.84. The transaction received HSR clearance, Gentherm expects to file a Form S-4, and management still expects the deal to close later this year. Guidance for 2026 (excluding the merger) remains $1.5–$1.6 billion revenue and $175–$195 million adjusted EBITDA; the company flagged approximately $20 million of incremental cost pressure from freight and commodity inflation and said recovery discussions with customers will begin in Q2.
Positive
- None.
Negative
- None.
Insights
Q1 showed record product revenue and improved margins, with cautious full-year guidance.
Gentherm reported $394 million product revenue and $49.3 million adjusted EBITDA, reflecting operational improvements and stronger Automotive Climate performance, particularly in China. Management maintained 2026 guidance of $1.5–$1.6 billion revenue despite the quarter's strength.
Near-term risks include an estimated $20 million of incremental cost headwinds from freight and commodities; recovery relies on commercial negotiations and timing differences between cost realization and pricing adjustments. Subsequent filings (the Form S-4) will clarify pro forma capital structure and merger-related charges.
Transaction progressing: HSR cleared and integration planning underway, but timing and synergies remain contingent.
Teams have formed an integration management office and held a kickoff summit; Modine Performance Technologies is planned to operate as a standalone division within Gentherm. Management models a combined path to $3.5B revenue and $500M+ earnings over five years.
Key items to watch in filings and next calls are the Form S-4 disclosures on expected synergies, transaction financing, timing, and estimated integration costs. Execution risk and regulatory conditions remain primary gating factors.